124 related articles for article (PubMed ID: 8671917)
1. Relative efficacy of haemoperfusion, haemodialysis and CAPD in the removal of procainamide and NAPA in a patient with severe procainamide toxicity.
Low CL; Phelps KR; Bailie GR
Nephrol Dial Transplant; 1996 May; 11(5):881-4. PubMed ID: 8671917
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics of procainamide in continuous ambulatory peritoneal dialysis.
Sica DA; Yonce C; Small R; Cefali E; Harford A; Poynor W
Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):59-64. PubMed ID: 2457560
[TBL] [Abstract][Full Text] [Related]
3. Use of procainamide in chronic ambulatory peritoneal dialysis: report of a case.
Kroboth PD; Mitchum K; Puschett JB
Am J Kidney Dis; 1984 Jul; 4(1):78-9. PubMed ID: 6204527
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic comparisons of twice daily and four times daily formulations of procainamide in patients with frequent ventricular premature depolarization.
Yang BB; Abel RB; Uprichard AC; Smithers JA; Forgue ST
J Clin Pharmacol; 1996 Jul; 36(7):623-33. PubMed ID: 8844445
[TBL] [Abstract][Full Text] [Related]
5. Comparison of transport of procainamide and N-acetylprocainamide from blood into the intestinal lumen with that into the peritoneal cavity in rats.
Arimori K; Hashimoto Y; Nakano M
Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):2050-2. PubMed ID: 1702691
[TBL] [Abstract][Full Text] [Related]
6. Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances.
Bauer LA; Black DJ; Lill JS; Garrison J; Raisys VA; Hooton TM
Antimicrob Agents Chemother; 2005 Apr; 49(4):1649-51. PubMed ID: 15793163
[TBL] [Abstract][Full Text] [Related]
7. Improved high-performance liquid chromatographic assay for the determination of procainamide and its N-acetylated metabolite in plasma: application to a single-dose pharmacokinetic study.
Lessard E; Fortin A; Coquet A; Bélanger PM; Hamelin BA; Turgeon J
J Chromatogr Sci; 1998 Jan; 36(1):49-54. PubMed ID: 9443381
[TBL] [Abstract][Full Text] [Related]
8. Effect of age, gender, and race on steady state procainamide pharmacokinetics after administration of procanbid sustained-release tablets.
Koup JR; Abel RB; Smithers JA; Eldon MA; de Vries TM
Ther Drug Monit; 1998 Feb; 20(1):73-7. PubMed ID: 9485559
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of N-acetylation of procainamide and renal clearance of N-acetylprocainamide by para-aminobenzoic acid in humans.
Tisdale JE; Rudis MI; Padhi ID; Svensson CK; Webb CR; Borzak S; Ware JA; Krepostman A; Zarowitz BJ
J Clin Pharmacol; 1995 Sep; 35(9):902-10. PubMed ID: 8786250
[TBL] [Abstract][Full Text] [Related]
10. Transport of procainamide and N-acetylprocainamide from blood into the intestinal lumen and intestinal dialysis by oral activated charcoal in rats with acute renal failure.
Arimori K; Nakano M
J Pharmacobiodyn; 1988 Jul; 11(7):504-11. PubMed ID: 2460613
[TBL] [Abstract][Full Text] [Related]
11. Procainamide toxicity in a patient with acute renal failure.
Rosansky SJ; Brady ME
Am J Kidney Dis; 1986 Jun; 7(6):502-6. PubMed ID: 2424305
[TBL] [Abstract][Full Text] [Related]
12. Combined high-efficiency hemodialysis and charcoal hemoperfusion in severe N-acetylprocainamide intoxication.
Kar PM; Kellner K; Ing TS; Leehey DJ
Am J Kidney Dis; 1992 Oct; 20(4):403-6. PubMed ID: 1384320
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic modeling and simulation of procainamide and N-acetylprocainamide in a patient receiving continuous renal replacement therapy: a novel approach to guide renal dose adjustments.
Mohamed AN; Abdelhady AM; Spencer D; Sowinski KM; Tisdale JE; Overholser BR
Am J Kidney Dis; 2013 Jun; 61(6):1046-8. PubMed ID: 23562328
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic levels of intravenous procainamide in neonates: a retrospective assessment.
Moffett BS; Cannon BC; Friedman RA; Kertesz NJ
Pharmacotherapy; 2006 Dec; 26(12):1687-93. PubMed ID: 17125432
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim alters the disposition of procainamide and N-acetylprocainamide.
Kosoglou T; Rocci ML; Vlasses PH
Clin Pharmacol Ther; 1988 Oct; 44(4):467-77. PubMed ID: 2458879
[TBL] [Abstract][Full Text] [Related]
16. Procainamide pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
Raehl CL; Moorthy AV; Beirne GJ
Nephron; 1986; 44(3):191-4. PubMed ID: 2431330
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humans.
Funck-Brentano C; Light RT; Lineberry MD; Wright GM; Roden DM; Woosley RL
J Cardiovasc Pharmacol; 1989 Sep; 14(3):364-73. PubMed ID: 2476614
[TBL] [Abstract][Full Text] [Related]
18. Hemoperfusion for treatment of N-acetylprocainamide intoxication.
Braden GL; Fitzgibbons JP; Germain MJ; Ledewitz HM
Ann Intern Med; 1986 Jul; 105(1):64-5. PubMed ID: 2424355
[No Abstract] [Full Text] [Related]
19. Mandibular and parotid salivary excretion of procainamide and N-acetylprocainamide after intravenous administration of procainamide to rats.
Watanabe J; Koyama I; Iwamoto K; Ozeki S
J Pharm Pharmacol; 1987 Nov; 39(11):912-6. PubMed ID: 2448449
[TBL] [Abstract][Full Text] [Related]
20. [Verification of therapeutic levels of procainamide and N-acetyl- procainamide in ventricular arrhythmia].
Sinkiewicz W; Marzec A; Jankowski A; Hoffmann A; Makuch K; Romański B
Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):458-60. PubMed ID: 1703654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
